By tapping the FTC, the Biden administration is hoping to send a message to drug companies that any moves to unfairly establish monopolies — and cost consumers money — will not be tolerated.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
